These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4226795)

  • 1. Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics.
    Crane GE; Paulson G
    Int J Neuropsychiatry; 1967 Jun; 3(3):286-91. PubMed ID: 4226795
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract]   [Full Text] [Related]  

  • 4. Cigarette smoking is associated with abnormal involuntary movements in the general male population--a study of men born in 1933.
    Nilsson A; Waller L; Rosengren A; Adlerberth A; Wilhelmsen L
    Biol Psychiatry; 1997 Mar; 41(6):717-23. PubMed ID: 9066996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and electroencephalographical studies in patients with involuntary movements.
    Kitagawa T
    Yonago Acta Med; 1972 Nov; 15(3):225-33. PubMed ID: 5028949
    [No Abstract]   [Full Text] [Related]  

  • 6. [Choreiform syndromes and durable or irreversible hyperkinesias after prolonged treatment with neuroleptic drugs].
    Bergouignan M; Fontanges X; Clèdes J
    Ann Med Psychol (Paris); 1966 Jul; 124(2):186-96. PubMed ID: 5967653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
    Crane GE
    Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V; Kemali D; Pacini A; Bertolino A; Lamura G
    Boll Soc Ital Biol Sper; 1971 Aug; 47(15):470-2. PubMed ID: 5158530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics].
    Gralewski Z
    Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of patients with pulmonary tuberculosis and mental disorders].
    Rudoĭ NM; Chubakov TCh
    Probl Tuberk; 1996; (2):17-9. PubMed ID: 8657685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications and limitations of action of an anti-tremor drug: CE 10010].
    Michaux L; Lecuyer R
    Ann Med Psychol (Paris); 1966 Dec; 124(5):664-70. PubMed ID: 5973300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in peripheral blood during treatment with some neuroleptics and thymoleptics].
    Kiczak J; Warnecka-Przybylska M; Wdowiak MW
    Psychiatr Pol; 1975; 9(3):275-81. PubMed ID: 1153559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of neuroleptics on the excretion of hallucinogens].
    Kanabus P; Stencka K
    Psychiatr Pol; 1974; 8(2):163-8. PubMed ID: 4830324
    [No Abstract]   [Full Text] [Related]  

  • 16. Movement disorders.
    Minagar A; Kelley RE
    Prim Care; 2004 Mar; 31(1):111-27. PubMed ID: 15110162
    [No Abstract]   [Full Text] [Related]  

  • 17. [The erythrocyte sedimentation rate (ESR) and treatment with neuroleptics].
    Ibsen KK; Kirk L
    Ugeskr Laeger; 1974 Jul; 136(28):1572-5. PubMed ID: 4210189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of some serum enzyme activity in the course of treatment with neuroleptics and thymoleptics].
    Kiczak J; Sliwińska-Przyjemska H; Warnecka--Przybylska M; Wdowiak MW
    Psychiatr Pol; 1976; 10(2):153-7. PubMed ID: 1273160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytologic study of cerebrospinal fluid in chronic psychiatric patients treated with neuroleptics (author's transl)].
    Rýznar J; Uhlír F
    Cesk Psychiatr; 1974 Apr; 70(2):93-7. PubMed ID: 4448007
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.